MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
- PMID: 31196010
- PMCID: PMC6567604
- DOI: 10.1186/s12885-019-5796-9
MiR-890 inhibits proliferation and invasion and induces apoptosis in triple-negative breast cancer cells by targeting CD147
Abstract
Background: Triple-negative breast cancer (TNBC) is a type of breast cancer with a high degree of malignancy. Because of the remarkable biological characteristics of high invasion, metastasis and recurrence, TNBC is often accompanied by a poor prognosis. As a molecular characteristic of TNBC, high expression of CD147 has been confirmed by a large number of studies. However, the mechanism of CD147 expression regulation in TNBC remains elusive. In this study, we investigated the roles of miR-890 in inhibiting CD147.
Methods: Quantitative Reverse Transcription-Polymerase Chain Reaction (qRT-PCR) was used to detect CD147 mRNA and miR-890 level, and western blotting was used to detect CD147 protein. Bioinformatics screening and 3'-Untranslated Region (3'-UTR) luciferase assays were used to analyze the microRNAs (miRNA) binding site. Cell proliferation, apoptosis and invasion were assessed by using CCK-8, flow cytometry and transwell assays.
Results: The upregulation of miR-890 inhibited cell proliferation and invasion, induced apoptosis in MDA-MB-231 and HCC-70 TNBC cells by negatively regulating its target gene, CD147, and the upregulation of CD147 rescued the inhibitory effects of miR-890. miR-890 targeted CD147 by binding to its 3'-UTR. Further results showed that the upregulation of miR-890 also inhibited the expression of MMPs, the downstream genes of CD147, and promoted the cleavage of Caspase-3. The CD147 recovery experiment was further confirmed by the activity changes in the downstream MMPs of CD147. In addition, it was confirmed that the effect of CD147 in promoting TNBC cell proliferation and invasion, inhibiting apoptosis was related to the change in caspase-3 activity.
Conclusion: The downregulation of miR-890 is the potential cause of high CD147 expression in TNBC, which can promote the malignant transformation of TNBC.
Keywords: CD147; Invasion; Proliferation; TNBC; miR-890.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.Cells. 2019 Nov 22;8(12):1492. doi: 10.3390/cells8121492. Cells. 2019. PMID: 31766744 Free PMC article. Review.
-
MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.Oncotarget. 2017 Mar 21;8(12):19455-19466. doi: 10.18632/oncotarget.14307. Oncotarget. 2017. PMID: 28038450 Free PMC article.
-
MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients.Eur Rev Med Pharmacol Sci. 2019 Dec;23(23):10433-10442. doi: 10.26355/eurrev_201912_19682. Eur Rev Med Pharmacol Sci. 2019. PMID: 31841197
-
microRNA-761 induces aggressive phenotypes in triple-negative breast cancer cells by repressing TRIM29 expression.Cell Oncol (Dordr). 2017 Apr;40(2):157-166. doi: 10.1007/s13402-016-0312-6. Epub 2017 Jan 4. Cell Oncol (Dordr). 2017. PMID: 28054302
-
Triple negative breast cancer in the era of miRNA.Crit Rev Oncol Hematol. 2021 Jan;157:103196. doi: 10.1016/j.critrevonc.2020.103196. Epub 2020 Dec 9. Crit Rev Oncol Hematol. 2021. PMID: 33307198 Review.
Cited by
-
MicroRNA-598 inhibits the growth of triple negative breast cancer cells by targeting JAG1.Exp Ther Med. 2021 Mar;21(3):235. doi: 10.3892/etm.2021.9666. Epub 2021 Jan 21. Exp Ther Med. 2021. PMID: 33603843 Free PMC article.
-
The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer.Nutrients. 2021 Apr 7;13(4):1212. doi: 10.3390/nu13041212. Nutrients. 2021. PMID: 33916931 Free PMC article. Review.
-
MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance and Applications in Human Triple-Negative Breast Cancer.Cells. 2019 Nov 22;8(12):1492. doi: 10.3390/cells8121492. Cells. 2019. PMID: 31766744 Free PMC article. Review.
-
The Effect of lncRNA SNHG3 Overexpression on Lung Adenocarcinoma by Regulating the Expression of miR-890.J Healthc Eng. 2021 Jul 8;2021:1643788. doi: 10.1155/2021/1643788. eCollection 2021. J Healthc Eng. 2021. Retraction in: J Healthc Eng. 2023 Aug 9;2023:9761493. doi: 10.1155/2023/9761493. PMID: 34306585 Free PMC article. Retracted.
-
CD147 Promotes Tumorigenesis via Exosome-Mediated Signaling in Rhabdomyosarcoma.Cells. 2022 Jul 22;11(15):2267. doi: 10.3390/cells11152267. Cells. 2022. PMID: 35892564 Free PMC article.
References
-
- Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, Senn HJ, Panel m Personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast Cancer 2013. Ann Oncol. 2013;24(9):2206–2223. doi: 10.1093/annonc/mdt303. - DOI - PMC - PubMed
-
- Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res. 1995;55(2):434–439. - PubMed
-
- Li Z, Ren Y, Wu QC, Lin SX, Liang YJ, Liang HZ. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines. Chin Med J. 2004;117(1):107–114. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous